Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 11/20 | 0.59 |
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.57 |
| ▸ | GLP1R | P43220 | 2/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.56 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29981974 | 1.00 | KISS1R (0.59) | KISS1RIL23RGLP1RECE1MUS81 | |
| SCHEMBL29982283 | 0.98 | KISS1R (0.62) | KISS1RIL23R | |
| SCHEMBL30401709 | 0.98 | KISS1R (0.62) | KISS1RIL23R | |
| SCHEMBL30401759 | 0.96 | KISS1R (0.61) | KISS1RIL23RGLP1RECE1MUS81 | |
| SCHEMBL29981789 | 0.89 | IL23R (0.58) | KISS1RIL23R | |
| SCHEMBL30974278 | 0.88 | IL23R (0.62) | IL23RGLP1RECE1MUS81 | |
| SCHEMBL29982290 | 0.88 | KISS1R (0.54) | KISS1RIL23R | |
| SCHEMBL29982442 | 0.88 | KISS1R (0.54) | KISS1RIL23R | |
| SCHEMBL30339295 | 0.88 | CCKBR (0.62) | IL23RGLP1RECE1MUS81PTH1R | |
| SCHEMBL29415985 | 0.87 | KISS1R (0.64) | KISS1RGLP1RECE1MUS81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203098-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | JCR PHARMACEUTICALS CO., LTD. (JP) | 2023-06-29 | — | — | US | claimed |
| EP-4108676-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | JCR Pharmaceuticals Co., Ltd. (JP) | 2022-12-28 | — | — | EP | claimed |
| CN-115151556-A | Human transferrin receptor binding peptides | JCR制药股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20240390508-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-11-28 | — | — | US | disclosed |
| EP-4389893-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE | Takeda Pharmaceutical Company Limited (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-20230203098-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | JCR PHARMACEUTICALS CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| WO-2023026994-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE | 武田薬品工業株式会社 | 2023-03-02 | — | — | WO | disclosed |
| EP-4108676-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | JCR Pharmaceuticals Co., Ltd. (JP) | 2022-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390508-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE | MUSK, TFRC, SLC7A1 | KISS1R 2887/4885IL23R 2841/4885GLP1R 1459/4885 |
| US-20230203098-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | TFRC, SLC3A2, SLC7A1 | KISS1R 1171/4885IL23R 1413/4885GLP1R 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.